tobramycin
A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
aminoglycoside antibioticARO:0000016
-
CHEBI:22479 - aminoglycoside antibiotic
ARO:0000016
Chemical structure
| Molecular formula | C18H37N5O9 |
|---|---|
| Charge | 0 |
| Average mass | 467.52 Da |
| Monoisotopic mass | 467.25913 Da |
| Source | ChEBI |
| InChIKey | NLVFBUXFDBBNBW-PBSUHMDJSA-N |
NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O
InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1
Also called
- (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside
- 3'-Deoxykanamycin B
- Nebramycin 6
- Nebramycin factir 6
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
- Tobracin (TN)
- Tobramycin
- Tobrex (TN)
- Gotabiotic
- Nebcin
- Tenebrimycin
- Tobracin
- Tobradistin
- Tobramaxin
- Tobramicin
- Tobramitsetin
- Tobramycetin
- Tobrex
Cross-references
- tobramycin
ARO:0000052 - cas:32986-56-4
- kegg.compound:C00397
- lincs.smallmolecule:LSM-6534
- pdb-ccd:TOY
- reaxys:1357507
- chembl:CHEMBL1747
- pubchem.compound:36294
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial agent
CHEBI:33282
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:0000052 |
tobramycin | antibioticmech:aro-2db7d91840 |
2026-08-30 |
| CHEBI | CHEBI:28864 |
tobramycin | antibioticmech:chebi-7bce6663cd |
2026-08-30 |
Molecular targets
antibiotic sensitive 16S rRNA NUCLEIC_ACID DIRECT_BINDING_TARGET
Mechanism summary
- Clinical status
- APPROVED
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Escherichia coli NCBITaxon:562 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0349 |
BioSample SAMN11953777 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | 16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0497 |
BioSample SAMN11953783 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | 16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2024 M100 S34. | 0297 |
BioSample SAMN04901687 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0346 |
BioSample SAMN11953774 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1149 |
BioSample SAMN34111336 |
EvidencePage data (JSON.gz) |
| Enterobacter cloacae complex NCBITaxon:354276 | — | 16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1151 |
BioSample SAMN34111338 |
EvidencePage data (JSON.gz) |
| Enterobacter cloacae complex NCBITaxon:354276 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1152 |
BioSample SAMN34111339 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1153 |
BioSample SAMN34111340 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1155 |
BioSample SAMN34111341 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1156 |
BioSample SAMN34111342 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1157 |
BioSample SAMN34111343 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1158 |
BioSample SAMN34111344 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1159 |
BioSample SAMN34111345 |
EvidencePage data (JSON.gz) |
| Enterobacter cloacae complex NCBITaxon:354276 | — | 8.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1160 |
BioSample SAMN34111346 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1161 |
BioSample SAMN34111347 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | 8.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1162 |
BioSample SAMN34111348 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1163 |
BioSample SAMN34111349 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | 8.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1106 |
BioSample SAMN19970475 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1107 |
BioSample SAMN31096620 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1268 |
BioSample SAMN33435241 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1269 |
BioSample SAMN33435242 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1270 |
BioSample SAMN33435243 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 1328 |
BioSample SAMN50502207 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | 16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0347 |
BioSample SAMN11953775 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | 8.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0495 |
BioSample SAMN11953781 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | 8.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35. | 0538 |
BioSample SAMN11953785 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | 16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; CDC/FDA AR Isolate Bank reports an R interpretation without a versioned breakpoint footnote on this isolate page. | 0033 |
BioSample SAMN04014874 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2024 M100 S34 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0078 |
BioSample SAMN04014919 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | >16.0 mg/L | — | Broth microdilution tobramycin MIC; modal MIC reported; interpreted using CLSI 2020 M100 S30 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0083 |
BioSample SAMN04014924 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | CDC/FDA AR Isolate Bank tobramycin MIC; interpreted using CLSI 2026 M100 Ed36 per the Panel 1394 footnote. | 1332 | — | EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | >16.0 mg/L | — | CDC/FDA AR Isolate Bank tobramycin MIC; interpreted using CLSI 2026 M100 Ed36 per the Panel 1394 footnote. | 1333 | — | EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | 8.0 mg/L | — | CDC/FDA AR Isolate Bank tobramycin MIC; interpreted using CLSI 2026 M100 S36 per the Panel 1394 footnote. | 1334 | — | EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_INACTIVATION 95
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| AAC(2')-Ia | ARO:3002523 | — | ||
| AAC(2')-Ib | ARO:3002524 | — | ||
| AAC(2')-Ic | ARO:3002525 | — | ||
| AAC(2')-Id | ARO:3002526 | — | ||
| AAC(2')-Ie | ARO:3002527 | — | ||
| AAC(3)-IIIa | ARO:3002536 | — | ||
| AAC(3)-IIIb | ARO:3002537 | — | ||
| AAC(3)-IIa | ARO:3002533 | — | ||
| AAC(3)-IIb | ARO:3002534 | — | ||
| AAC(3)-IIc | ARO:3002535 | — | ||
| AAC(3)-IId | ARO:3004623 | — | ||
| AAC(3)-IIe | ARO:3004621 | — | ||
| AAC(3)-IIg | ARO:3005085 | — | ||
| AAC(3)-IVa | ARO:3002539 | — | ||
| AAC(3)-IVb | ARO:3005061 | — | ||
| AAC(3)-Ib/AAC(6')-Ib3 bifunctional protein | ARO:3002600 | — | ||
| AAC(6')-29a | ARO:3002583 | — | ||
| AAC(6')-29b | ARO:3002584 | — | ||
| AAC(6')-31 | ARO:3002585 | — | ||
| AAC(6')-32 | ARO:3002586 | — | ||
| AAC(6')-I-43 | ARO:3004641 | — | ||
| AAC(6')-I-48 | ARO:3004638 | — | ||
| AAC(6')-I30 | ARO:3002588 | — | ||
| AAC(6')-I33 | ARO:3002587 | — | ||
| AAC(6')-IIa | ARO:3002594 | — | ||
| AAC(6')-IIb | ARO:3002595 | — | ||
| AAC(6')-IIc | ARO:3002596 | — | ||
| AAC(6')-Ia | ARO:3002545 | — | ||
| AAC(6')-Iaa | ARO:3002571 | — | ||
| AAC(6')-Iad | ARO:3002572 | — | ||
| AAC(6')-Iae | ARO:3002573 | — | ||
| AAC(6')-Iaf | ARO:3002574 | — | ||
| AAC(6')-Iai | ARO:3002575 | — | ||
| AAC(6')-Iaj | ARO:3003677 | — | ||
| AAC(6')-Iak | ARO:3003199 | — | ||
| AAC(6')-Ian | ARO:3003200 | — | ||
| AAC(6')-Iap | ARO:3007204 | — | ||
| AAC(6')-Ib | ARO:3002546 | — | ||
| AAC(6')-Ib' | ARO:3003676 | — | ||
| AAC(6')-Ib-Hangzhou | ARO:3002592 | — | ||
| AAC(6')-Ib-SK | ARO:3002593 | — | ||
| AAC(6')-Ib-Suzhou | ARO:3002591 | — | ||
| AAC(6')-Ib-cr1 | ARO:3002547 | — | ||
| AAC(6')-Ib-cr3 | ARO:3005112 | — | ||
| AAC(6')-Ib-cr4 | ARO:3005114 | — | ||
| AAC(6')-Ib-cr5 | ARO:3005115 | — | ||
| AAC(6')-Ib-cr6 | ARO:3005116 | — | ||
| AAC(6')-Ib-cr7 | ARO:3005117 | — | ||
| AAC(6')-Ib-cr8 | ARO:3005118 | — | ||
| AAC(6')-Ib-cr9 | ARO:3005119 | — | ||
| AAC(6')-Ib10 | ARO:3002581 | — | ||
| AAC(6')-Ib11 | ARO:3002582 | — | ||
| AAC(6')-Ib3 | ARO:3002576 | — | ||
| AAC(6')-Ib4 | ARO:3002577 | — | ||
| AAC(6')-Ib7 | ARO:3002578 | — | ||
| AAC(6')-Ib8 | ARO:3002579 | — | ||
| AAC(6')-Ib9 | ARO:3002580 | — | ||
| AAC(6')-Ic | ARO:3002549 | — | ||
| AAC(6')-Ie-APH(2'')-Ia bifunctional protein | ARO:3002597 | — | ||
| AAC(6')-If | ARO:3002553 | — | ||
| AAC(6')-Ig | ARO:3002554 | — | ||
| AAC(6')-Ih | ARO:3002555 | — | ||
| AAC(6')-Ii | ARO:3002556 | — | ||
| AAC(6')-Iid | ARO:3002589 | — | ||
| AAC(6')-Iih | ARO:3002590 | — | ||
| AAC(6')-Ij | ARO:3002557 | — | ||
| AAC(6')-Ik | ARO:3002558 | — | ||
| AAC(6')-Il | ARO:3004635 | — | ||
| AAC(6')-Im | ARO:3004629 | — | ||
| AAC(6')-Ip | ARO:3002559 | — | ||
| AAC(6')-Iq | ARO:3002560 | — | ||
| AAC(6')-Ir | ARO:3002561 | — | ||
| AAC(6')-Is | ARO:3002562 | — | ||
| AAC(6')-Isa | ARO:3002563 | — | ||
| AAC(6')-It | ARO:3002564 | — | ||
| AAC(6')-Iu | ARO:3002565 | — | ||
| AAC(6')-Iv | ARO:3002566 | — | ||
| AAC(6')-Iw | ARO:3002567 | — | ||
| AAC(6')-Ix | ARO:3002568 | — | ||
| AAC(6')-Iy | ARO:3002569 | — | ||
| AAC(6')-Iz | ARO:3002570 | — | ||
| AAC(6')-Va | ARO:3009655 | — | ||
| ANT(2'')-Ia | ARO:3000230 | — | ||
| ANT(3'')-II-AAC(6')-IId bifunctional protein | ARO:3002598 | — | ||
| ANT(4')-IIa | ARO:3002624 | — | ||
| ANT(4')-IIb | ARO:3002625 | — | ||
| ANT(4')-Ia | ARO:3002623 | — | ||
| ANT(4')-Ib | ARO:3003905 | — | ||
| APH(2'')-IIIa | ARO:3002636 | — | ||
| APH(2'')-IVa | ARO:3002637 | — | ||
| APH(2'')-Ie | ARO:3002634 | — | ||
| APH(2'')-If | ARO:3004191 | — | ||
| APH(2'')-Ig | ARO:3002669 | — | ||
| aac(6')-Ib-cr10 | ARO:3007770 | — | ||
| aac(6')-Ib-cr11 | ARO:3007771 | — |
ANTIBIOTIC_TARGET_ALTERATION 12
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Escherichia coli 16S rRNA (rrsB) mutation conferring resistance to tobramycin | ARO:3003408 | — | ||
| Mycobacteroides abscessus 16S rRNA mutation conferring resistance to tobramycin | ARO:3003237 | — | ||
| Mycobacteroides chelonae 16S rRNA mutation conferring resistance to tobramycin | ARO:3003516 | — | ||
| armA | ARO:3000858 | — | ||
| rmtA | ARO:3000859 | — | ||
| rmtB | ARO:3000860 | — | ||
| rmtC | ARO:3000861 | — | ||
| rmtD | ARO:3002667 | — | ||
| rmtD2 | ARO:3004677 | — | ||
| rmtG | ARO:3002668 | — | ||
| rmtH | ARO:3003198 | — | ||
| sgm | ARO:3000862 | — |
ANTIBIOTIC_EFFLUX 7
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| AcrAD-TolC | ARO:3004082 | — | ||
| AmrAB-OprM | ARO:3002981 | — | ||
| CrcB | ARO:3005049 | — | ||
| Klebsiella pneumoniae KpnGH-TolC | ARO:3004598 | — | ||
| MexXY-OprA | ARO:3003038 | — | ||
| MexXY-OprM | ARO:3003032 | — | ||
| acrD | ARO:3000491 | — |
ANTIBIOTIC_TARGET_REPLACEMENT 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| dfrL | ARO:3007456 | — |
UNKNOWN 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| PvrR | ARO:3003688 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank tobramycin-resistant Escherichia coli isolate MIC observation.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank tobramycin-resistant Klebsiella pneumoniae isolate MIC observation.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank tobramycin-resistant Acinetobacter baumannii isolate MIC observation.
-
CURATED_RESISTANT_TAXA
Corrected the CDC/FDA AR Isolate Bank 0349 breakpoint context from CLSI 2024 M100 S34 to CLSI 2025 M100 S35.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank tobramycin-resistant Escherichia coli MIC observation from isolate 0346.
-
CURATED_RESISTANT_TAXA
Added 13 stable-URL CDC/FDA AR Isolate Bank tobramycin-resistant Multi-Mechanism panel MIC observations for AR-1149, AR-1151, AR-1152, AR-1153, AR-1155, AR-1156, AR-1157, AR-1158, AR-1159, AR-1160, AR-1161, AR-1162, and AR-1163.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1106.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1107.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1268.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1269.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1270.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1328.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Klebsiella pneumoniae MIC observation for AR-0347.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Escherichia coli MIC observation for AR-0495.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 tobramycin-resistant Escherichia coli MIC observation for AR-0538.
-
CURATED_RESISTANT_TAXA
Added CDC/FDA AR Isolate Bank Panel 1227 isolate 0033 Acinetobacter baumannii tobramycin MIC 16 mg/L with interpretation R; preserved source Unknown, BioSample SAMN04014874, Study ID CarbaNP-02, and MLST ST85(Pasteur)/ST1089(Oxford) in evidence notes.
-
CURATED_RESISTANT_TAXA
Fixes #428. Clarified the CDC/FDA AR Isolate Bank Panel 1227 isolate 0033 tobramycin evidence note for BioSample SAMN04014874 to include both normalized and original MIC units, and revised the same-row curation-history wording to call out the stable isolate-detail URL.
-
CURATED_RESISTANT_TAXA
Fixes #429. Restored the original 2026-09-18T10:14:31Z AR Bank 0033 tobramycin curation-history text so provenance remains append-only; left the #428 correction as a later clarification of normalized/original MIC units and the stable CDC/FDA AR Isolate Bank isolate-detail URL.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 1227 tobramycin-resistant Acinetobacter baumannii MIC observation for AR-0078; preserved source Pus, BioSample SAMN04014919, Study ID CarbaNP-47, and MLST ST229(Pasteur)/ST203(Oxford) in evidence notes.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 1227 tobramycin-resistant Acinetobacter baumannii MIC observation for AR-0083; preserved source Unknown, BioSample SAMN04014924, Study ID CarbaNP-52, and MLST ST1(Pasteur)/ST231/1604(Oxford) in evidence notes.
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 1394 tobramycin-resistant Pseudomonas aeruginosa MIC observation for AR-1332; preserved source Urine, Study ID IMP-10, unavailable BioSample accession, and MLST ST357(Pasteur) in evidence notes.
-
CURATED_RESISTANT_TAXA
Added two stable-URL CDC/FDA AR Isolate Bank Panel 1394 tobramycin-resistant Pseudomonas aeruginosa MIC observations for AR-1333 and AR-1334; preserved sources Urine and P-trap water, Study IDs IMP-11 and IMP-12, unavailable BioSample accessions, and MLST ST2731(Pasteur)/ST235(Pasteur) in evidence notes.
-
STRUCTURED_ACTIVITY_BIOSAMPLE_ACCESSIONS
Structured BioSample accessions on 29 activity_spectrum observation(s) where evidence notes already named exactly one accession.